Adalimumab weekly vs placeboChange in DLQI score (LOCF) · participants with hidradenitis suppurativa1 finding from 1 reviewInterventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes onlyno estimate extracted1 study · 102 participantsModerate
Adalimumab every other week vs placeboChange in DLQI score (LOCF) · participants with hidradenitis suppurativa1 finding from 1 reviewInterventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 124 participantsHigh